0000899243-17-010064.txt : 20170412 0000899243-17-010064.hdr.sgml : 20170412 20170412163131 ACCESSION NUMBER: 0000899243-17-010064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170410 FILED AS OF DATE: 20170412 DATE AS OF CHANGE: 20170412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Scott A. CENTRAL INDEX KEY: 0001703394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 17758287 MAIL ADDRESS: STREET 1: C/O CYTODYN INC. STREET 2: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-10 0 0001175680 CytoDyn Inc. CYDY 0001703394 Kelly Scott A. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 Stock Option (right to buy) 0.61 2017-04-10 4 A 0 7123 0.00 A 2017-05-31 2027-04-10 Common Stock 7123 7123 D Subject to stockholder approval of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, at the next annual meeting. /s/ Michael D. Mulholland, as attorney-in-fact 2017-04-12